- Home
- PNST vs NRSN Comparison
PNST vs NRSN Comparison
Compare PNST & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNST
- NRSN
- Stock Information
- Founded
- PNST 2007
- NRSN 2017
- Country
- PNST United States
- NRSN Israel
- Employees
- PNST N/A
- NRSN N/A
- Industry
- PNST Blank Checks
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- PNST Finance
- NRSN Health Care
- Exchange
- PNST Nasdaq
- NRSN Nasdaq
- Market Cap
- PNST 18.1M
- NRSN 17.8M
- IPO Year
- PNST N/A
- NRSN 2021
- Fundamental
- Price
- PNST $0.32
- NRSN $1.09
- Analyst Decision
- PNST Strong Buy
- NRSN Hold
- Analyst Count
- PNST 3
- NRSN 1
- Target Price
- PNST $2.50
- NRSN N/A
- AVG Volume (30 Days)
- PNST 87.0K
- NRSN 159.3K
- Earning Date
- PNST 02-19-2025
- NRSN 04-04-2025
- Dividend Yield
- PNST N/A
- NRSN N/A
- EPS Growth
- PNST N/A
- NRSN N/A
- EPS
- PNST N/A
- NRSN N/A
- Revenue
- PNST $123,579,000.00
- NRSN N/A
- Revenue This Year
- PNST $15.43
- NRSN N/A
- Revenue Next Year
- PNST $17.79
- NRSN N/A
- P/E Ratio
- PNST N/A
- NRSN N/A
- Revenue Growth
- PNST 11.06
- NRSN N/A
- 52 Week Low
- PNST $0.31
- NRSN $0.51
- 52 Week High
- PNST $4.26
- NRSN $2.33
- Technical
- Relative Strength Index (RSI)
- PNST 39.45
- NRSN 44.12
- Support Level
- PNST $0.31
- NRSN $1.12
- Resistance Level
- PNST $0.50
- NRSN $1.24
- Average True Range (ATR)
- PNST 0.06
- NRSN 0.08
- MACD
- PNST -0.00
- NRSN -0.01
- Stochastic Oscillator
- PNST 5.56
- NRSN 13.57
About PNST Pinstripes Holdings Inc.
Pinstripes Holdings Inc is an experiential dining and entertainment concept combining exceptional Italian-American cuisine with bowling, bocce, and private events. It owns and operates around 17 restaurants in the USA. The company designs and constructs large-format locations that are each 26,000 to 38,000 square feet of interior space, plus additional outdoor patio space that includes outdoor dining, bocce courts, fire-pits, and decorative fountains.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.